Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special Populations
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) Pathogens
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Global Request for Proposals – Pfizer Clostridioides difficile (C. difficile) Research Collaboration
    Release Date:
    Review Process: Pfizer Internal
    Call for Collaborator(s) Vaccines France, Germany
    Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy Care
    Release Date:
    Partner: The Japanese Society for Cutaneous Immunology and Allergy
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Geriatric Anorexia – Educational Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Advances in Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2021/2022 Global Cachexia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Closing Knowledge Gaps in Moderate-to-Severe Atopic Dermatitis for Allergists
    Release Date:
    Partner: American College of Allergy, Asthma & Immunology (ACAAI)
    Review Process: Expert Review Panel
    Education Inflammation & Immunology USA
    Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers and Primary Care Physicians
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Pediatric Growth Hormone Deficiency Education
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    2021 I&I RE-CUP-IT REal world data Competitive grant in Ulcerative colitis Program - ITalian experiences
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
    Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Antimicrobial Stewardship (AMS) Programs in USA, Europe, Japan, South Korea, Australia and New Zealand
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Cardiac Amyloidosis Mentor mATTch pRogram
    Release Date:
    Partner: Amyloidosis Foundation
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Assessing Gaps in BRAF Testing in Melanoma & Colorectal Cancer in Developing Regions
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Algeria, Argentina, Brazil, Colombia, Iraq, Kuwait, Lebanon, Mexico, Qatar, Saudi Arabia, United Arab Emirates
    Astellas and Pfizer Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA